Improved diagnosis and management of one of the most common cancers in men – prostate cancer – could result from research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease.
Results of a study now published in the journal Endocrine-Related Cancer have shown that the presence of certain molecules in seminal fluid indicates not only whether a man has prostate cancer, but also the severity of the cancer.
Read more . . .
The Latest on: Prostate cancer biomarkers
[google_news title=”” keyword=”Prostate cancer biomarkers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Prostate cancer biomarkers
- New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsieson April 18, 2024 at 6:17 pm
Researchers have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm from more aggressive ...
- Urine Test Accurately Detected High-Grade Prostate Canceron April 18, 2024 at 1:57 pm
A new 18-gene urine test demonstrated higher diagnostic accuracy for high-grade prostate cancer compared with existing biomarker tests, a study showed.
- New urine test has higher diagnostic accuracy for prostate canceron April 18, 2024 at 10:11 am
A new urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically significant cancers than PSA and other existing biomarker tests, according to ...
- MyProstateScore 2.0 Clinically Validated in New JAMA Oncology Studyon April 18, 2024 at 10:00 am
Lynx Dx, a leader in innovative diagnostic solutions, hailed new peer-reviewed research published today in the Journal of the American Medical Association (JAMA) Oncology that validates the efficacy ...
- Avoid Unnecessary Biopsies: New Urine-Based Test Detects High-Grade Prostate Canceron April 18, 2024 at 7:59 am
New urine-based test looks at 18 genes and was specifically developed to pick out those cancers that need immediate treatment over the slow-growing type. Researchers at the University of Michigan Roge ...
- New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer patientson April 16, 2024 at 1:30 pm
A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
- Discovery of Prostate Cancer Biomarkers by Microarray Gene Expression Profilingon April 11, 2024 at 5:00 pm
During the past two decades, cancer biomarker discovery has been boosted by the advent of new technologies for high-throughput molecular profiling, such as microarray analysis and mass spectrometry.
- Here's How Often Low-Risk People Should Be Tested for Prostate Canceron April 9, 2024 at 9:08 am
New research is helping to better inform patients and doctors about when it is appropriate to seek out PSA testing and subsequent screening. For low-risk men, a PSA test once every 5 years may be ...
- Discovery of Prostate Cancer Biomarkers by Microarray Gene Expression Profilingon April 7, 2024 at 5:00 pm
Cite this: Discovery of Prostate Cancer Biomarkers by Microarray Gene Expression Profiling - Medscape - Jan 01, 2010. * Studies using microdissected samples. All other studies used grossly ...
- PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screeningon April 5, 2024 at 9:00 pm
A single round of prostate cancer screening that included a prostate-specific antigen (PSA) test, a kallikrein panel, and an MRI detected one additional high-grade cancer per 196 men and one low-grade ...
via Bing News